Survey data for COVID-19 vaccine preference analysis in the United Arab Emirates

Abstract

In response to the call for interdisciplinary research on the potential effects of the coronavirus pandemic [1] , this article presents a novel data set on individuals’ COVID-19 vaccine preferences in the United Arab Emirates (UAE). The menu of our stated preference survey questionnaire is framed based on the World Health Organization's (WHO) SAGE working group on immunization developed matrix of vaccine determinants [2] , which was itself informed by a systematic review of peer reviewed and grey literature, and by the expertise of the working group. Our survey was designed in a bilingual (Arabic and English) format, using Google Forms platform and delivered to respondents aged 18 years and older using the snowball sampling method between July 4th and August 4th 2020, gathering a total of 1109 responses. Study participants were recruited across all seven emirates of the UAE (see figure 1). As presented in the conceptual framework (see figure 2), the data set comprises (i) respondents socio-economic and demographic information, (ii) respondents willingness to spend time, and money to get the Covid-19 vaccine, and (iii) the vaccine determinants identified by the WHO's SAGE working group on immunization.

COVID-19 Vaccine Development in a Quadruple Helix Innovation System: Uncovering the Preferences of the Fourth Helix in the UAE

“…Other prospective investigations could also consider such future avenues in other national settings, as a way of contributing further to the evidence based policy making required to eradicate the COVID-19 pandemic from communities around the world. Source: Authors' construction using data openly available at [59] and formally published in [58]. Source: Authors' construction using data openly available at [59] and formally published in [58].…”

“…Source: Authors' construction using data openly available at [59] and formally published in [58]. Source: Authors' construction using data openly available at [59] and formally published in [58]; * * * p < 0.001, * * p < 0.01, * p < 0.05. Source: Authors' construction using data openly available at [59] and formally published in [58]; * * * p < 0.001, * * p < 0.01, * p < 0.05.…”

“…Vaccine Outcome Variables (n = 1109). Authors' construction using data openly available at[59] and formally published in[58]. Socio-economic and demographic characteristics of the participants (n = 1109).…”

United States COVID-19 Vaccination Preferences (CVP): 2020 Hindsight

“…A similar study was conducted by Kreps and colleagues in July 2020, well before the first-generation vaccines were known to be efficacious and such plans were disseminated [5]. Between May and November 2020, many noteworthy health preference studies examined various aspects of COVID-19 in the United States [6] and in other countries [7][8][9][10][11][12][13]. Hopefully, many more studies will follow, building an evidentiary basis to inform the development of public health programs [14].…”

A High Rate of COVID-19 Vaccine Hesitancy Among Arabs: Results of a Large-scale Survey

“…Other studies have been conducted in Saudi Arabia (n =1000) 11 and (n=3,101) 12 , Egypt (n=559) 13 , Jordan (n =3100) 14 , and the UAE (n =1,109) 15 . With the Arab nations having significant variations socioeconomically, politically and in the measures taken to control the pandemic, the study of reactions to and acceptance of the vaccine becomes necessary.…”